Eudaimonia Advisors’s CME Group CME Stock Holding History

Eudaimonia Advisors’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$997K	Buy	4,631 +188	+4%	+$39.5K	0.53%	55
2023 Q4	$936K	Buy	4,443 +75	+2%	+$16K	0.61%	46
2023 Q3	$875K	Sell	4,368 -16	-0.4%	-$3.18K	0.61%	49
2023 Q2	$812K	Buy	4,384 +29	+0.7%	+$5.36K	0.55%	52
2023 Q1	$834K	Sell	4,355 -357	-8%	-$64.6K	0.56%	54
2022 Q4	$792K	Hold	4,712	–	–	0.54%	50
2022 Q3	$835K	Sell	4,712 -139	-3%	-$27.5K	0.58%	50
2022 Q2	$993K	Sell	4,851 -115	-2%	-$24.4K	0.68%	40
2022 Q1	$1.18M	Hold	4,966	–	–	0.68%	39
2021 Q4	$1.14M	Buy	+4,966	New	+$1.09M	0.67%	38

Other funds holding CME

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Eudaimonia Advisors's CME Position: Q1 2024 in Review

Eudaimonia Advisors increased its CME Group (CME) stake by 4.2% in Q1 2024, buying an estimated $39.5K and bringing the position to 4,631 shares worth $997K. The position accounts for 0.53% of the portfolio, ranked #55.

Eudaimonia Advisors first reported a position in CME in Q4 2021 and has held it in 10 quarters since. The position peaked at $1.18M in Q1 2022. 1,372 funds tracked by Wall St. Rank hold CME as of Q1 2024.

Eudaimonia Advisors held 4,631 shares of CME Group worth $997K as of Q1 2024.
Eudaimonia Advisors bought 188 CME Group shares in Q1 2024, an estimated $39.5K.
CME Group made up 0.53% of Eudaimonia Advisors's portfolio in Q1 2024, its #55 holding.
Eudaimonia Advisors first reported a position in CME Group in Q4 2021 and has held it in 10 quarters since.
Eudaimonia Advisors's CME Group position peaked at $1.18M in Q1 2022.
1,372 funds tracked by Wall St. Rank held CME Group as of Q1 2024.

Based on Eudaimonia Advisors's 13F filing for Q1 2024, filed 25 Apr 2024.